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Abstract
Background: Uterine leiomyoma is the most common benign tumor in reproductive-age women. Each leiomyoma is
thought to be a benign monoclonal tumor arising from a single transformed myometrial smooth muscle cell; however, it is
not known what leiomyoma cell type is responsible for tumor growth. Thus, we tested the hypothesis that a distinct stem/
reservoir cell-enriched population, designated as the leiomyoma-derived side population (LMSP), is responsible for cell
proliferation and tumor growth.
Principal Findings: LMSP comprised approximately 1% of all leiomyoma and 2% of all myometrium-derived cells. All LMSP
and leiomyoma-derived main population (LMMP) but none of the side or main population cells isolated from adjacent
myometrium carried a mediator complex subunit 12 mutation, a genetic marker of neoplastic transformation. Messenger
RNA levels for estrogen receptor-a, progesterone receptor and smooth muscle cell markers were barely detectable and
significantly lower in the LMSP compared with the LMMP. LMSP alone did not attach or survive in monolayer culture in the
presence or absence of estradiol and progestin, whereas LMMP readily grew under these conditions. LMSP did attach and
survive when directly mixed with unsorted myometrial cells in monolayer culture. After resorting and reculturing, LMSP
gained full potential of proliferation. Intriguingly, xenografts comprised of LMSP and unsorted myometrial smooth muscle
cells grew into relatively large tumors (3.6761.07 mm
3), whereas xenografts comprised of LMMP and unsorted myometrial
smooth muscle cells produced smaller tumors (0.5460.20 mm
3,p ,0.05, n=10 paired patient samples). LMSP xenografts
displayed significantly higher proliferative activity compared with LMMP xenografts (p,0.05).
Conclusions: Our data suggest that LMSP, which have stem/reservoir cell characteristics, are necessary for in vivo growth of
leiomyoma xenograft tumors. Lower estrogen and progesterone receptor levels in LMSP suggests an indirect paracrine
effect of steroid hormones on stem cells via the mature neighboring cells.
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Introduction
Uterine leiomyomas, the most common pelvic tumor in women,
are benign smooth muscle tumors originating from the myome-
trium [1]. Uterine leiomyomas occur in 60% of women by the age
of 45 years and cause symptoms in approximately 30% of the cases
[2,3]. These symptoms include pelvic pain, discomfort, and
abnormal bleeding. Uterine leiomyomas are also an important
cause of infertility and they are the most common medical reason
for hysterectomy [3,4]. Despite the high prevalence, the exact
pathophysiology of uterine leiomyomas is still unknown.
Somatic stem cells are a subset of cells residing in normal adult
tissues that, through asymmetric division, retain their ability to
self-renew while producing daughter cells that go on to differen-
tiate and play a role in tissue regeneration and repair [5,6].
Likewise, tumor initiating cells are a subset of cells within a tumor
cell population, which, also through asymmetric division, retain
the ability to reconstitute tumors [7,8]. The side population (SP)
phenotype was first described in bone marrow, where a somatic
stem cell population was identified based on its ability to extrude
the DNA binding dye Hoechst 33342, a phenomenon that is
associated with the expression of ATP-binding cassette transporter
G2 [8]. In general, the SP phenotype is thought to be a universal
marker of somatic stem cells and has been used to isolate them
from many adult tissues, such as the myometrium, endometrium
and mammary gland [9,10,11,12].
Leiomyomas are thought to be monoclonal tumors arising from
the myometrium; however, it is not known what cell population in
the myometrium gives rise to these tumors [13,14]. Several
recurrent genetic aberrations, such as trisomy of chromosome 12,
deletions in 7q, and mutation affecting the mediator complex
subunit 12 (MED12) or the high mobility group AT-hook 2
(HMGA2) gene were reported in uterine leiomyomas
[15,16,17,18]. As in other diseases, these genetic abnormalities
and tumor stem cells are considered to play pivotal roles in the
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stem cells in human uterine leiomyoma growth, we examined
leiomyoma derived SP cells (LMSP).
Methods
Preparation of human myometrial and leiomyoma cells
Myometrium and leiomyoma were obtained at surgery from
women (range 27–52 years) undergoing hysterectomy or myo-
mectomy, in addition to some basic endocrine information (e.g.,
day of menstrual cycle, parity, whether oral contraception is being
taken). Written informed consent was obtained from each patient
and the use of human tissue specimens was approved by the
Institutional Review Board for Human Research at Northwestern
University, Chicago, IL. None of these cases had any previous
history of uterine cancer, and all samples were confirmed by
histopathological examination to be free of malignancy. The
tissues were prepared as previously described [9].
Hoechst 33342 and Pyronin Y (PY) staining
The dissociated cells were re-suspended at a concentration of
2610
6 cells/ml in calcium- and magnesium-free Hanks-balanced
salt solution containing 2% fetal bovine serum (FBS). Hoechst
33342 (Sigma-Aldrich, St. Louis, MO) was then added at a final
concentration of 5 mg/ml and the sample was incubated at 37uC
for 90 min. A parallel aliquot was stained with Hoechst 33342 dye
in the presence of 50 mM reserpine (Sigma-Aldrich). After
incubation, the cells were centrifuged at 1500 rpm for 7 minutes,
re-suspended in 2 ml of cold FACS solution, and further incubated
with 1 mg/ml propidium iodide (PI, Sigma-Aldrich) to label non-
viable cells. The cells were kept on ice at all times after staining
with the Hoechst 33342 dye. The Hoechst dye- and PI-treated
cells were subjected to flow cytometric analysis to separate the side
population of myometrial cells (MMSP), main population of
myometrial cells (MMMP), LMSP, and main population of
leiomyoma cells (LMMP). For co-staining with Hoechst 33342
and PY, sorted LMSP and LMMP were washed twice in FACS
solution, incubated with 1 mg/mL Hoechst 33342 together with
50 mM reserpine at 37uC for 45 minutes, and then, without any
additional washing, incubated with 3.3 mM PY (Polysciences,
Warrington, PA) for another 45 minutes. The cells were washed
once in an excess volume of FACS solution and subjected to FACS
analysis by MoFlo (Cytomation, Fort Collins, CO) and LSR
Fortessa (BD Biosciences, San Jose, CA). Cells co-treated with
Hoechst and reserpine or treated with PY alone were used as
negative controls.
FACS analysis
Myometrial and leiomyoma cells were sorted by MoFlo and
analyzed using the Flowjo software (Tree Star Ashland, OR).
Myometrial and leiomyoma cells were re-suspended in FACS
solution at 1–5610
7 cells/ml. The antibodies used for FACS were
conjugated with fluorescein isothiocyanate (FITC) or phycoery-
thrin (PE) (Table 1). Hoechst 33342 was excited at 350 nm, and
the fluorescence emission was detected using 405/BP (band pass)
30 and 570/BP20 optical filters for Hoechst blue and Hoechst red,
respectively. A 550-nm long-pass dichroic mirror (Omega Optical
Inc., Brattleboro, VT) was used to separate the emission
wavelengths. Both Hoechst blue and red fluorescence intensities
are shown on a linear scale. PI fluorescence was measured through
a 630/BP30 optical filter after excitation at 488 nm with an argon
laser, and a live cell gate was defined to exclude PI-positive cells.
After collecting 1610
5 events, the SP population was defined as
previously reported [11,19,20]. Forward scatter, side scatter, and
PI gating excluded residual erythrocytes, debris, doublets, and
dead cells. The purity of the cell populations was verified directly
after sorting as .98%. The viability of sorted cells exceeded 90%
as assessed by trypan blue exclusion.
RNA extraction and quantitative analysis using real-time
RT-PCR
RNA extraction and real-time RT-PCR were performed as
described previously [21,22]. Glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) transcripts were measured as an internal
control. Primer pairs used for each PCR reaction are as listed in
the Table 2.
Genomic DNA sequencing
Sequencing for MED12 in myometrial and leiomyoma cells was
performed by the Sanger DNA sequencing method. DNA from
each sample was extracted using DNeasy blood and tissue kit
(Qiagen, Germantown, MD). The desired DNA fragment was first
amplified using AmpliTaqGold enzyme (Applied Biosystems,
Foster City, CA). The PCR products were purified using
QIAquick PCR Purification Kit (Qiagen) and the sequencing
reactions were performed utilizing the Big Dye Terminator v.3.1
Kit (Applied Biosystems) according to the manufacturer’s instruc-
tions. Sequencing was performed on an ABI3730 Automatic DNA
Sequencer (Applied Biosystems) at the Northwestern University
Genomics Core Facility. The sequence graphs were analyzed both
manually and on a computer with the Sequence Scanner (Applied
Biosystems) program.
Table 1. List of antibodies used in this study.
Antgigen Clone Isotype Supplier
CD31 (FACS) WM59 FITC-conjugated mouse IgG1 BD Pharmingen (San Jose, CA)
CD45 (FACS) HI30 FITC-conjugated mouse IgG1 BD Pharmingen
CD73 (FACS) AD2 PE-conjugated mouse IgG1 BD Pharmingen
CD90 (FACS) 5.00E+10 PE-conjugated mouse IgG1 BD Pharmingen
CD105 (FACS) 266 FITC-conjugated mouse IgG1 BD Pharmingen
STRO-1 (FACS) STRO-1 mouse IgM R & D Systems (Minneapolis, MN)
a-smooth muscle actin 1A4 mouse IgG2a DAKO Cytomation (Glostrup, Denmark)
Estrogen recetor 1 SP1 rabbit IgG Lab Vision (Kalamazoo, MI)
Progesterone receptor SP2 rabbit IgG Lab Vision
doi:10.1371/journal.pone.0036935.t001
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Both LMSP and LMMP were cultured in DMEM/F12 1:1
(GIBCO/BRL, Grand Island, NY) containing 10% FBS and
grown in a humidified atmosphere with 5% CO2 at 37uC. For
hormone treatment, cells were treated in the presence or absence
of 17b-Estradiol (E2;1 0
27 M; Sigma-Aldrich) and/or R5020 (P;
10
27 M; Perkin-Elmer, Boston, MA) in phenol red-free DMEM/
F12 with 10% charcoal-stripped FBS for 7 days. An MTS assay
using the Cell Titer 96 Aqueous One Solution Cell Proliferation
Assay (Promega Corp., Madison, WI) was performed according to
the manufacturer’s instructions. The effects of the E2 and/or P on
the viability of LMSP and LMMP were evaluated. Co-culturing in
two separate compartments or with indirect contact with
myometrial cells (MM) was performed using Transwell Permeable
Supports (0.4-mm pore; Corning Incorporated, Pittston, PA). Side
or main cell populations in mixed co-cultures with MM at a 1:1
ratio were identified after initially dye-labeling each cell type. We
labeled the cytosolic membranes of LMSP or LMMP cells using
PKH-26 (red; Sigma-Aldrich), whereas myometrial cells were
labeled by PKH-67 (green; Sigma-Aldrich). Cells originating from
LMSP or LMMP in mixed co-cultures were identified using long-
lasting status PKH-26.
Immunofluorescence and histological analysis
Indirect immunofluorescence staining was performed described
previously [11,23]. Background fluorescence was determined by
applying the secondary conjugated antibody alone and by
replacement of the primary antibody with nonimmune serum.
Slides were successively stained with various antibodies as listed in
the Table 1, followed by incubation with secondary antibodies.
Images were collected using an inverted Axiovert 200 fluorescent
microscope (Carl Zeiss, Gottingen, Germany).
Transplantation analysis
Northwestern University’s Animal Care and Use Committee
approved all procedures involving animals in this study. The
protocol for the acquisition of surgical specimens was approved by
Northwestern University’s Institutional Review Board. LMSP or
LMMP were co-cultured with primary myometrial cells for 4–6
days. The ratio of LMSP to myometrial cells before xenografting
was 1:9; and the ratio of LMMP to myometrial cells was 1:7. Cells
were collected from the culture plates by trypsin digestion and
suspended into rat-tail collagen (type I) solution (BD Bioscience,
San Jose, CA) at 10
5 cells per 10 ml. We have successfully used this
method to study the hormonal response of human endometrial
tissue [24,25]. With this technique, the low-density collagen gel
consists mostly of water, and thus the pellet volume (10 ml) does
not reflect the starting volume of the tumor. When cell pellets are
incubated at 37uC overnight as floating cultures, they become
smaller than 1 mm in diameter due to contraction of the collagen
by the leiomyoma cells. Therefore, the estimated starting volume
of the cell graft is smaller than 0.6 mm
3. The grafting procedure
was performed as described previously [25]. Cell pellets were
grafted onto opposing kidneys of adult female non-obese diabetic-
scid (IL2Rc
null) mouse hosts (Jackson Laboratory, Bar Harbor,
ME). The cell pellets are high in water content, and thus, they
become smaller under the pressure of the subrenal capsule. The
estimated starting volume of tissue grafts under the renal capsule
was approximately 1 mm
3. According to our previous report,
estrogen and progesterone are known to promote the growth of
cells derived from uterine fibroids when transplanted under the
kidney capsule [25]. For this reason, all hosts were ovariectomized
and supplemented with sc implantation of 80 mg progesterone (P4;
Sigma-Aldrich) plus 80 mgE 2 (Sigma-Aldrich). These doses were
chosen because previous studies demonstrated that they were able
to sustain systemic E2 and P4 levels within cycling women [26].
The effects of ovariectomy and hormone treatments were
confirmed by the gross appearance and histology of the host
female reproductive tracts. The presence of hormone pellets was
also confirmed at the time of termination of the host.
Data analysis
Tumor volume was measured using the program ImageJ
(National Institutes of Health, http://rsbweb.nih.gov.ezproxy.
galter.northwestern.edu/ij/index.html). P value was calculated
using the unpaired Student’s t-test. P value less than 0.05 were
considered statistically significant.
Table 2. List of primer sets used in this study.
Gene Primer sets Accession number
Estrogen receptor 1 (ESR1) 59-CACCAACCAGTGCACCATCATTG-39 NM_001122740
59-AAGGTTGGCAGCTCTCATGTC-39
Estrogen receptor 2 (ESR2) 59-CCATGATCCTGCTCAATTCC-39 NM_001437
59-CTCTTGGCAATCACCCAAAC-39
Progesterone receptor (PGR) 59-CATTTGCACAAACCTGATGG-39 NM_001202474
59-CATGGTGTACAAGGCCACTG-39






Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)5 9-GAAGGTGAAGGTCGGAGTC-39 NM_002046
59-GAAGATGGTGATGGGATTTC-39
doi:10.1371/journal.pone.0036935.t002
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Leiomyoma have a lower percentage of SP cells than
normal myometrium
Since the SP phenomena has recently been shown to identify
putative myometrial somatic stem cells in mice [5] and humans
[9,27], we evaluated differences in the SP between the myome-
trium and leiomyoma. Single cell suspensions of normal myome-
trium and leiomyoma tissue prepared from patients were each
stained with Hoechst 33342 dye and analyzed by flow cytometry
to identify the SP. PI staining was used to evaluate cell viability. In
the representative experiment shown in Fig. 1A, there were nearly
two-fold more SP cells in the normal myometrium of this patient
compared to that found in the leiomyoma tissue. When reserpine,
an inhibitor of ATP binding cassette transporter activity, was
included as a control, no SP cells were detected, suggesting that
the Hoechst dye efflux from the SP was due to ATP binding
cassette transporter activity. Comparison of the two tissues from 10
patients showed that the normal myometrium had a consistently
and significantly larger SP than leiomyomas (2.07%60.46 vs.
1.19%60.23, p,0.05, n=10; Fig. 1B). Based on our recent
finding that MMSP have a myometrial stem cell phenotype [9], we
further characterized the SP of leiomyoma to identify leiomyoma
stem cells.
LMSP represent an immature or undifferentiated cell
population
Real-time RT-PCR analysis of mRNA derived from isolated
MMSP, MMMP, LMSP, and LMMP demonstrated that the
expression levels of estrogen receptor-a (ESR1), progesterone
receptor (PGR), and the smooth muscle cell markers, including
aSMA, were present at very low levels in LMSP compared with
both LMMP and whole leiomyoma tissues (Fig. 1C and D). These
results suggest that LMSP represents an immature or undifferen-
tiated cell population just after isolation, consistent with our
observation that LMSP differentiate into uterine leiomyoma cells
after co-culture with myometrial cells.
Figure 1. Isolation and characterization of human MMSP and LMSP. (A) (Left upper) Distribution of the SP and MP cells within all Hoechst
33342-stained living cells isolated from human myometrium. (Right upper) Addition of 50 mM reserpine resulted in the disappearance of the MMSP
fraction. (Left lower) Distribution of SP and MP cells isolated from human leiomyoma. (Right lower) Addition of 50 mM reserpine resulted in the
disappearance of the LMSP fraction. (B) Average % SP of normal myometrium and leiomyomas from 10 different patients are shown (2.07%60.46 vs.
1.19%60.23, P,0.05). Error bars represent SEM. (C) mRNA expression of ovarian steroid receptors and (D) smooth muscle cell markers was examined
by real-time RT-PCR and normalized for GAPDH expression. Each bar indicates the mean 6 SEM of the relative expression obtained from three
independent experiments using three individual samples. *, P,0.05.
doi:10.1371/journal.pone.0036935.g001
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of blood cells, endothelial cells, or bone marrow-derived
mesenchymal stem cells (MSC)
Phenotypic analyses using flow cytometry demonstrated that
LMSP contain 5.6% CD31-positive cells and 2.3% CD45-positive
cells. These results suggest that cell surface marker expression on
LMSP differ from those on endothelial progenitor cells or
hematopoietic stem cells. The percentage of CD31-positive cells
in LMSP is lower compared with MMSP, whereas CD45
expression is rare in both LMSP and MMSP. We also analyzed
the expression of the bone marrow MSC markers CD73, CD90,
CD105 and Stro-1. In LMSP, expression levels of the markers
were 23.3% for CD73, 27.1% for CD90, 2.3% for CD105, and
3.9% for stro-1 (Fig. 2A and B). Considering that these markers
are commonly found on MSC, our data suggest that LMSP are
not identical to MSC.
Cell cycle analysis reveals that LMSP are quiescent
An important characteristic of hematopoietic and other tissue-
specific stem cells is that they remain dormant or quiescent,
arrested in the G0 phase of the cell cycle and protected from
depletion or exhaustion [28,29,30]. Exit from G0 and entry into
G1 are associated with an increase in transcription, which can be
measured by staining with pyronine Y (PY), an RNA-specific dye.
Co-staining with PY and Hoechst 33342, followed by flow
cytometry analysis, revealed that 83.67%65.73 of LMSP but
only 58.50%66.06 of LMMP were in the G0 phase (Fig. 2C),
which is consistent with the existence of quiescent stem cells within
LMSP.
Figure 2. Cell surface marker antigens in LMSP. (A) Expression patterns of endothelial cell surface markers (CD31, Platelet Endothelial Cell
Adhesion Molecule-1) and hematopoietic (CD45, Leukocyte common antigen) in MMSP, LMSP (red); and MMMP, LMMP (blue). In LMSP, most of the
cells were negative for endothelial and hematopoietic cell markers. (B) Expression patterns of bone marrow mesenchymal stem cell surface markers
(CD73, CD90, CD105, STRO-1) in MMSP, LMSP (red); and MMMP, LMMP (blue). These bone mesenchymal cell surface antigens were not able to
identify LMSP. Mouse FITC-labeled IgG1 (BD Biosciences) was used as an isotypic control for staining of total myometrial or leiomyoma cells (black).
(C) Cell cycle status of LMSP and LMMP was determined by Hoechst 33342 and Pyronin Y staining. The left lower quadrant corresponds to the G0
phase. Flow cytometry analysis revealed that 83.67%65.73 of LMSP but only 58.50%66.06 of LMMP were in the G0 phase.
doi:10.1371/journal.pone.0036935.g002
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to a leiomyoma cell lineage
Recently, mutations in the MED12 gene have been reported in
the majority of leiomyoma tissues and cells [16]. We directly
sequenced the MED12 gene in 3 pairs of normal myometrium and
adjacent leiomyoma tissues, as well as in main population and SP
cells isolated from these samples. We found mutations involving a
substitution of guanine (G) at the 131 bp position to either alanine
(A) or cytosine (C) in leiomyoma tissue and LMSP and LMMP
isolated from leiomyoma tissues, but not in adjacent myometrial
tissues or their main population or SP cells (Fig. 3). Two patients
had the same c.131G.A mutation shown in the upper panel of
Fig. 3, and the third patient had the c.131G.C mutation shown in
the lower panel. These two missense mutations affected the amino
acid residue at codon 44, giving rise to conversions G44A and
G44D (Fig. 3). These data suggest that LMSP carry a genetic
mutation that may lead to tumorigenic transformation in cells
already been committed to a leiomyoma cell lineage.
Mixed co-culture with myometrial smooth muscle cells
enhances initial attachment and spread and eventual
differentiation and growth of LMSP
To further characterize LMSP in vitro, we attempted to culture
and expand these cells using conventional media supplemented
with E2 and/or P. LMSP cells cultured alone never attached to
plastic or spread up to 4 weeks in culture (Fig. 4A). LMSP also
Figure 3. Sequence chromatograms showing somatic mutations in MED12 codon 44 in LMSP. Examples of genomic DNA sequencing
traces in codon 44-mutated samples are shown. Mutated bases are indicated by arrows.
doi:10.1371/journal.pone.0036935.g003
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Permeable Supports were used to create separate compartments
of confluent myometrial cells and seeded LMSP (Fig. 4B). Finally,
we tried a mixed co-culture system, in which equal numbers
(50,000) of LSMP and myometrial smooth muscle cells were
mixed 1:1 and maintained in the same culture dish. In mixed co-
culture, the LMSP attached and spread together with unsorted
myometrial cells in vitro in DMEM/F12 1:1 10% FBS without any
hormonal treatment (Fig. 4C), reaching confluence in a 6-cm
culture dish within 2 weeks. In this co-culturing system, we labeled
LMSP or LMMP using PKH-26 fluorescent dye. No fusion
between the two cell types was observed. After mixed co-culture,
the final ratio of LMSP to LMMP was approximately 1:9. This
result indicates that LMSP did attach and spread but did not
increase significantly in number during the first mixed co-culture.
These findings suggest that cell-cell interactions and/or myome-
trial cell-derived secretory factors may be required for attachment
and survival of LMSP.
LMSP differentiate to LMMP and proliferate after co-
culture
After grown to confluence in the first mixed co-culture plate
with myometrial cells, LMSP cells were sorted by flow cytometry
using a PKH-26 dye, and their gene expression profile was
determined using real-time PCR. The steroid hormone receptors,
ESR1 and PGR, and smooth muscle cell markers were expressed
at the same level in LMSP, LMMP, and cultured cells from whole
leiomyoma tissue (Fig. 4D and E). Immunostaining showed that
protein expression of aSMA was not different between LMSP and
LMMP after these cells were maintained in mixed co-culture
(Fig. 4F). Because LMSP did not express these markers before
mixed co-culture with myometrial smooth muscle cells, these
results indicate that LMSP differentiate to a cell type similar to
LMMP during co-culture. Moreover, after sorting and re-
culturing, the pure LMSP population grew to full confluence
indicating that the differentiated LMSP population now gained the
potential for proliferation similar to that observed in LMMP
Figure 4. Cell culture of LMSP. (A) Effects of E2 and/or P on the viability of LMSP as determined by the MTS assay. Each bar indicates the mean 6
SEM of the absorbance at 490 nm obtained from three independent experiments using three individual samples. *, P,0.05. (B) Effects of indirect co-
culturing with MM on the viability of LMSP. *, P,0.05. (C) Side or main populations in mixed co-cultures with MM at a 1:1 ratio were identified after
initially dye-labeling each cell type. Cells originating from LMSP, LMMP, and MM in mixed co-cultures were identified using long-lasting status PKH-26
(red) or PKH-67 (green). Scale bars, 100 mm. (D) mRNA expression of the ovarian steroid receptors and (E) smooth muscle cell markers was examined
by real-time RT-PCR and normalized for GAPDH expression. Each bar indicates the mean 6 SEM of the relative expression obtained from three
independent experiments using three individual samples. *, P,0.05. (F) Expression of aSMA protein in LMSP and LMMP after culturing. Scale bars,
50 mm (upper), 100 mm (lower).
doi:10.1371/journal.pone.0036935.g004
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was 100% (Fig. 4F). FACS analysis was performed to demonstrate
the purity of LMSP and LMMP (control) cell types.
Generation of human leiomyoma-like tumors from LMSP
in immunodeficient mice
Single-cell suspensions of 100,000 cells obtained from mixed co-
culture systems were transplanted under the kidney capsule of
ovariectomized immunosuppressed mice treated with E2 and P4
for 12 weeks (see Materials and Methods). Each cell pellet from a
co-culture system included myometrial smooth muscle cells (MM)
plus LMMP or MM plus LMSP. Mice inoculated with a single cell
suspension (100,000 cells) cultured from whole myometrium (MM
only) were used as negative controls, as these cells never grow into
tumors [25]. To assess the capacity for tumorigenesis, each
xenografted cell pellet was analyzed for (i) tumor formation, (ii) the
3 dimensions and volume of the tumor, (iii) protein expression
using immunohistochemistry (Fig. 5). We demonstrated that both
LMSP+MM and LMMP+MM were capable of generating human
leiomyoma tumors; however the tumor size derived from
LMSP+MM was significantly larger (3.67 mm
361.07) compared
with LMMP+MM-derived tumors (0.54 mm
360.20, p,0.05,
n=10 paired patient samples; Fig. 5A and B). The tumors were
characterized by the presence of aSMA-positive cells in the renal
capsule (Fig. 5C). We confirmed the expression of estrogen
receptor (ER) and progesterone receptor (PR) in all the xenografts
obtained from animals grafted with LMSP+MM. Consistent with
the formation of larger tumors, LMSP+MM-derived tumor cells
displayed significantly higher proliferation as determined by a
higher Ki67 labeling index (2.38%60.12) compared with
LMMP+MM-derived tumors (0.35%60.08) (Fig. 5C and D).
Discussion
Uterine leiomyomas are monoclonal tumors, with growth of the
neoplasm occurring via clonal expansion from a single cell; this
raises the possibility for development of new, targeted therapeutic
interventions [31]. Our results reinforce the hypothesis that LMSP
are likely involved in leiomyoma tumorigenesis. Most leiomyomas
contain specific genetic mutations suggesting that transformation
of normal myocytes into abnormal myocytes is required at some
point during the genesis of a leiomyoma [16]. This process appears
to be quite common, in view of the high prevalence of microscopic
leiomyomas. We believe that LMSP arise from this myometrial
transformation, though the timing of this transformation has not
been elucidated and may occur in adults or during an embryonic
stage.
Figure 5. Generation of leiomyoma tumors from LMSP. (A) Macroscopic visualization of the transplanted site 12 weeks after
xenotransplantation. (B) Xenografts were analyzed in terms of tumor volume. Each bar indicates the mean 6 SEM. *, P,0.05, n=10 paired
patient samples. (C) Original tissue and generated tumor were analyzed by immunohistochemistry. Nuclei were stained with DAPI (blue). Scale bars,
100 mm. D, Ki 67 labeling index was calculated in transplanted tumors.
doi:10.1371/journal.pone.0036935.g005
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Marked pregnancy-induced expansion of the human uterus,
mainly composed of myometrial cells, is repeated multiple times
throughout the reproductive life of an individual. As uterine
leiomyomas are thought to be derivatives of myometrial cells
[13,14], we hypothesize that a population of putative stem/
reservoir cells that support growth exists within the leiomyoma. In
support of this hypothesis, the Hoechst-stained cells contained a
small fraction of SP cells that were resting in G0 phase, a
characteristic of stem cells that allows them to persist in various
tissues. Real-time RT-PCR data revealed that the LMSP rarely
expressed steroid hormone receptors and smooth muscle cell
markers. However, after culture, these markers were expressed
naturally at the same levels as seen in LMMP and the total
leiomyoma fraction. These results indicate that LMSP represent a
population of cells that exist in an undifferentiated state within the
leiomyoma that have the potential to differentiate into uterine
leiomyoma cells within the environment of the uterine myome-
trium.
Steroid hormones play a role in the growth of uterine
leiomyomas and endometrium [4,32,33,34,35]. Upregulation of
ESR1, PGR and aromatase in leiomyoma tissue were reported
[36]. The enzyme aromatase, which is encoded by the CYP19A1
gene produces estrogens, appears to be an important regulator of
estrogen response in leiomyomas. Progesterone, through its
receptor, PGR also increase leiomyoma growth via inhibiting
apoptosis and promoting cell proliferation [37,38,39].
To follow our previous work, we continued to employ Hoechst
33342 based isolation of SP cells to study stem/reservoir cell
biology in uterine leiomyoma [9]. It would desirable to use an
independent methodology such as cell sorting via a surface antigen
for the isolation of a leiomyoma cell population enriched in stem
cells. Unfortunately, such a marker to be used for this purpose has
not been published to date.
Intriguingly, we found that LMSP have tumorigenic capacity
under E2+P4 stimulation, despite our finding that LMSP are
negative for ESR1 and PGR. In mammary structures of humans
and mice, mammary stem cells, despite being void of ESR1 and
PGR themselves, are subject to regulation in both number and
repopulating ability by steroid hormones, particularly progester-
one [40,41,42,43]. We hypothesize that paracrine factors mediate
signals from steroid receptor-positive adjacent to LMSP. The most
important characteristic of stem cells is their ability to generate
tumors in immunocompromised mice. Tumors originating from
LMSP grew larger than those originating from LMMP, confirm-
ing the capacity of leiomyomas to initiate and sustain tumor
growth.
Thorough characterization of LMSP is necessary to understand
the complex mechanisms underlying the pathogenesis of leiomy-
oma, and our procedure for isolating and cultivating LMSP have
made such studies possible. The elucidation of the functions and
cellular properties of LMSP will broaden our understanding of
leiomyoma pathophysiology and will be the focus of future studies.
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